$77.63
arrow_drop_up0.85%Key Stats | |
---|---|
Open | $77.00 |
Prev. Close | $76.97 |
EPS | -0.86 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 76.80 | 78.15 |
52 Week Range | 45.50 | 84.89 |
Ratios | |
---|---|
EPS | -0.86 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder